Illinois Municipal Retirement Fund Buys 2,517 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Illinois Municipal Retirement Fund grew its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 24.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,813 shares of the medical instruments supplier's stock after acquiring an additional 2,517 shares during the period. Illinois Municipal Retirement Fund owned 0.05% of ICU Medical worth $1,988,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in ICUI. Creative Planning lifted its holdings in shares of ICU Medical by 58.6% during the third quarter. Creative Planning now owns 6,193 shares of the medical instruments supplier's stock worth $1,128,000 after buying an additional 2,287 shares in the last quarter. Allworth Financial LP increased its position in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 100 shares during the period. State of Alaska Department of Revenue raised its stake in ICU Medical by 16.0% in the 3rd quarter. State of Alaska Department of Revenue now owns 13,938 shares of the medical instruments supplier's stock worth $2,539,000 after purchasing an additional 1,921 shares in the last quarter. Amalgamated Bank boosted its holdings in ICU Medical by 13.1% in the 3rd quarter. Amalgamated Bank now owns 7,067 shares of the medical instruments supplier's stock valued at $1,288,000 after purchasing an additional 816 shares during the period. Finally, Principal Financial Group Inc. grew its position in shares of ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after purchasing an additional 25,031 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of research firms have recently weighed in on ICUI. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective on the stock in a research note on Wednesday, December 11th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. Finally, KeyCorp raised their price target on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $199.67.

ICU Medical Price Performance

NASDAQ:ICUI traded up $0.41 during mid-day trading on Tuesday, reaching $141.97. The stock had a trading volume of 138,831 shares, compared to its average volume of 211,132. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26. The stock has a market capitalization of $3.48 billion, a PE ratio of -30.98 and a beta of 0.63. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock has a 50-day simple moving average of $160.16 and a two-hundred day simple moving average of $166.21.

Insider Activity

In other news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 6.70% of the company's stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.